Targeting the apoptotic pathway is an effective option to improve or develop new chemotherapy to help treat cancer, but it is necessary to systematically review the role of BCL-2 family proteins in regulating apoptosis and cancer treatment. This evidence concerns the gene BCL2 and cancer.